Vimarsana
Biggest News Aggregation in the World

Page 7 - Brigham Hyde News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brigham Hyde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brigham Hyde Today - Breaking & Trending Today

Atropos Health Wins Prestigious UCSF Rising Star Award - Vimarsana News

Atropos Health Wins Prestigious UCSF Rising Star Award

/PRNewswire/ -- Atropos Health, the leader in delivering real-world evidence at the point and pace of care, was named a Rising Star in the Clinical Diagnostic...

Atropos Health Partners with Syntegra to Broaden Access to Data-Driven Clinical Care - Vimarsana News

Atropos Health Partners with Syntegra to Broaden Access to Data-Driven Clinical Care

/PRNewswire/ -- Syntegra, a leader in synthetic data generation, and Atropos Health, the leader in providing physicians and researchers with research-grade...

Atropos Health Partners with Syntegra to Broaden Access to Data-Driven Clinical Care - Vimarsana News

Atropos Health Partners with Syntegra to Broaden Access to Data-Driven Clinical Care

SAN FRANCISCO, Nov. 1, 2022 /PRNewswire/ -- Syntegra, a leader in synthetic data generation, and Atropos Health, the leader in providing physician...

QuantHealth Raises $2.6 Million Seed Round to Provide Comprehensive Clinical Trial Simulation Solution - Vimarsana News

QuantHealth Raises $2.6 Million Seed Round to Provide Comprehensive Clinical Trial Simulation Solution

/PRNewswire/ -- QuantHealth, an AI-powered clinical trial design startup, today announced its emergence from stealth, along with a $2.6 million seed financing...

Stanford spinout raises $14M for its point-of-care physician consult service - Vimarsana News

Stanford spinout raises $14M for its point-of-care physician consult service

Atropos Health, a startup spun out of Stanford University that provides point-of-care physician consults, recently raised $14 million in Series A funding. The company will use the money to further develop the oncology consult product it is building with ASCO, as well as grow its commercial team.